New Product Planning
New Product Planning
Right. From the Start.
Early asset teams face a unique challenge: how to make confident, long-term decisions when uncertainty is high. We help realize your vision, providing support so you can make decisions that shape early asset strategy and optimize the full clinical and commercial value of your asset.
How We Do It
We understand your early commercial needs and the critical questions to ask at each stage to obtain fresh perspectives, deliver truly differentiated strategies and ultimately give you the competitive edge needed for future market success.
We contextualize data within the big picture, translating complexity into a compelling narrative that engages the entire organization and facilitates alignment in decision making throughout the early asset development journey.
Why Work with Us?
Our unique blend of expert capabilities, including competitor, customer and scientific insight, therapy area expertise, and medical and commercial strategy, provide the foundation for a true integrated and collaborative partnership. These also enable us to challenge your cross-functional team through different lenses, creating an aligned view of the future landscape.
Ways We Can Help
All our projects and programs are tailored to your unique context and challenges; however, these are some of the most common types of support we provide.
We collaborate with your organization's various functions, challenging perspectives, foreseeing opportunities and establishing a unified vision for your asset. We’ll share integrated insights and comprehensive market landscape analyses, define strategic opportunities and facilitate informed decision making.
Our approach allows you to go beyond the dynamic present and align on life cycle opportunities for your asset within your organization.
The future presents endless possibilities. We specialize in identifying the key drivers of change, assessing their impact and foreseeing potential outcomes for your market and brand.
By leveraging diverse customer insights, competitive dynamics and macro trends, we provide clarity, synthesis and alignment on priority future world scenarios. This empowers you to navigate the uncertainties ahead, rallying your cross-functional team around shared market assumptions and stress-test asset or portfolio strategies.
We develop forward-thinking and thought-provoking TPPs by combining deep scientific knowledge with extensive clinical trial experience. We work alongside disease area experts to define the benchmark for additional value in your landscape. We specialize in crafting provocative scenarios that engage and challenge healthcare professionals.
Our TPPs integrate differentiated claims and novel endpoints that are fully aligned with your customers’ current and future market needs, driving innovation and advancing patient care.
We develop insights using our innovative demand studies approach, focusing on three key points: market scenarios, deep customer understanding and calibration.
We leverage our market experience and quantitative expertise to help you clearly define the scenarios you need your study to explore, ensuring that there is wide alignment before progressing with your research.
Our methodologies are rooted in real-world prescribing situations to closely model physician choices and gain a deeper understanding of the perceived value of your asset to customers within the future landscape.
Finally, our precise calibration techniques cut through survey bias and transform insights into engaging and clearly actionable points that grant greater confidence in your forecasts.
Our strategic framework and methodical approach to evaluating opportunities not only facilitates alignment between the teams but also sets a definitive path for development, enhancing the asset’s value throughout its life cycle.
By integrating scientific analysis with commercial foresight, we can identify and prioritize viable opportunities, ensuring strategic clarity, as well as financial and clinical solidity. This enables you to make well-informed decisions that drive current and future pipeline success, including clear clinical development plan choices based on investment, returns and associated risks.
Our Expertise Goes Beyond
Explore more of our service expertise and discover the wide range of perspectives and deep pool of knowledge from which we draw.
Debbie Allman
Senior Vice President
Areas of expertise:
Brand Strategy & Planning | Disease Area & Portfolio Strategy | Launch Excellence | New Product Planning
Dr. Olga Fidalgo González
Associate Vice President
Areas of expertise:
Clinical Development Strategy | Competitive Strategy | Disease Area & Portfolio Strategy | Launch Excellence | Medical & Scientific Consulting | New Product Planning
Easha Ghildyal
Vice President
Areas of expertise:
Clinical Development Strategy | Competitive Strategy | New Product Planning
Ready to Go Beyond?
Want to Know More About the Power of Prescience?
Whether you have a potential project or just want to find out more about our work, our team and how we can help you unlock innovation, please get in touch.
Contact Us
